Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × olokizumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Arthritis, Rheumatoid 1

Interventions

Rituximab 527 Cyclophosphamide 422 Vincristine 218 Doxorubicin 190 fludarabine phosphate 176 Etoposide 168 Prednisone 166 fludarabine 162 Methotrexate 161 Cytarabine 157 Filgrastim 124 Dexamethasone 123 Lenalidomide 121 Granulocyte Colony-Stimulating Factor 115 Whole-Body Irradiation 105 ibrutinib 97 Mycophenolic Acid 96 Bendamustine Hydrochloride 90 Tacrolimus 87 Melphalan 85 Calcium Dobesilate 82 Bortezomib 80 Peripheral Blood Stem Cell Transplantation 79 Busulfan 78 obinutuzumab 63 ofatumumab 59 Radiotherapy 57 Cyclosporine 55 Antilymphocyte Serum 55 Alemtuzumab 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03120949 2023-10-12

CREDO 4

R-Pharm

Phase 3 Completed

2,106 enrolled 30 charts

Arthritis, Rheumatoid, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡